IMMUCELL CORP /DE/ (ICCC) › Cash & EquivalentsIMMUCELL CORP /DE/ (ICCC) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2008: $1.20M2009: $975.5K2010: $1.40M2011: $781.5K2012: $2.67M2013: $2.27M2014: $850.0K2015: $1.57M2016: $5.15M2017: $3.80M2018: $2.52M2019: $6.29M2020: $6.95M2021: $10.19M2022: $5.79M2023: $978.7K2024: $3.76M2025: $3.81M$3.81M2008Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$3.81M+1.3%2024$3.76M+284.0%2023$978.7K-83.1%2022$5.79M-43.1%2021$10.19M+46.6%2020$6.95M+10.4%2019$6.29M+149.6%2018$2.52M-33.6%2017$3.80M-26.2%2016$5.15M+227.4%2015$1.57M+85.1%2014$850.0K-62.6%2013$2.27M-15.1%2012$2.67M+242.1%2011$781.5K-44.1%2010$1.40M+43.4%2009$975.5K-18.7%2008$1.20M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share